More than half a dozen major drugmakers are participating in the Trump administration's speedier review program for new ...

The U.S. Food and Drug Administration has delayed reviews of two drugs chosen for the Trump administration's new fast-track ...

Three key themes emerged across the mifepristone documents: consistent safety findings, lack of ideological bias in staff ...

The institution handed over wall texts and other materials as part of the White House's targeted inquiry into the museum ...

The White House says the Smithsonian Institution must submit materials about current and upcoming exhibitions and events for ...

The National Council on Teacher Quality has given failing grades to three public universities in Maine for how their teacher preparation programs teach reading ...

For organizations that conduct background checks, 2025 was not just about tracking new laws. It was about rethinking how ...

According to an official press release, the AI-powered eSignature features that make dense legal language easier to understand are built on DocuSign's Intelligent Agreement Management platform, ...

FDA delays drug reviews for two priority voucher drugs amid safety and efficacy concerns, extending timelines for Sanofi and Disc Medicine products.

The federal government has unveiled the next steps in its national gun buyback program — and Canadians will have about two ...

Republican election officials welcome the review, which relies on a federal verification tool, but they say they have not ...

New transparency driven framework aims to improve safety, consistency, and long term results for high stress professionals ...